Completed NA INTERVENTIONAL 2-arm NCT05022641

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

Sponsor: National Cancer Institute (NCI)

Conditions Hypercalcemia Parathyroid Adenoma Parathyroid Cancer Parathyroid Neoplasms Primary Hyperparathyroidism

Updated 9 times since 2021 Last updated: Aug 8, 2025 Started: Dec 1, 2021 Primary completion: May 31, 2024 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05022641, this NA trial focuses on Hypercalcemia and Parathyroid Adenoma and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 9 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Aug 2025 — Sep 2025 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Feb 2023 — Oct 2023 [monthly]

Recruiting NA
Feb 2022 — Feb 2023 [monthly]

Recruiting NA
Nov 2021 — Feb 2022 [monthly]

Recruiting NA
Sep 2021 — Nov 2021 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Michigan
Vanderbilt University

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States